Evidence map›Paper›PMID 32400345›Full record

ReviewThe American journal of tropical medicine and hygiene2020

Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research.

Daniel G Colley, Fiona M Fleming, Sultani H Matendechero, Stefanie Knopp, David Rollinson, Jürg Utzinger, Jennifer D Castleman, Nupur Kittur, Charles H King, Carl H Campbell and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. SCORE Studies on the Impact of Drug Treatment on Morbidity due toThe American journal of tropical medicine and hygiene · 2020
    Pooled it
  3. Trial
  4. SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission.The American journal of tropical medicine and hygiene · 2020
    Trial
  5. Trial
  6. Article
  7. Review
  8. UrogenitalOpen forum infectious diseases · 2025
    Article
  9. Article
  10. Improved Assessment ofOpen forum infectious diseases · 2024
    Article
  11. Detecting twoFrontiers in parasitology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 6 countries.

Daniel G Colley1Schistosomiasis Consortium for Operational Research and Evaluation (SCORE), Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Fiona M Fleming3Department of Infectious Disease Epidemiology, Schistosomiasis Control Initiative, London, United Kingdom.
Sultani H Matendechero4Division of Communicable Disease Prevention and Control, Neglected Tropical Diseases Unit, Ministry of Health, Nairobi, Kenya.
Stefanie Knopp5Swiss Tropical and Public Health Institute, Basel, Switzerland.
David Rollinson7Department of Life Sciences, Wolfson Wellcome Biomedical Laboratories, Natural History Museum, London, United Kingdom.
Jürg Utzinger5Swiss Tropical and Public Health Institute, Basel, Switzerland.
Jennifer D Castleman1Schistosomiasis Consortium for Operational Research and Evaluation (SCORE), Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Nupur Kittur1Schistosomiasis Consortium for Operational Research and Evaluation (SCORE), Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Charles H King1Schistosomiasis Consortium for Operational Research and Evaluation (SCORE), Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Carl H Campbell1Schistosomiasis Consortium for Operational Research and Evaluation (SCORE), Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Fatma M Kabole9Neglected Diseases Programme, Ministry of Health of Zanzibar, Zanzibar, United Republic of Tanzania.
Safari Kinung'hi10National Institute for Medical Research (NIMR), Mwanza Centre, Mwanza, United Republic of Tanzania.
Reda M R Ramzy11National Nutrition Institute, General Organization for Teaching Hospitals and Institutes, Cairo, Egypt.
Sue Binder1Schistosomiasis Consortium for Operational Research and Evaluation (SCORE), Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
University of Georgia · USGeneral Organization For Teaching Hospitals and Institutes · EGMinistry of Health · KENational Institute for Medical Research · TZNatural History Museum · GBSwiss Tropical and Public Health Institute · CHUniversity of Basel · CHZanzibar University · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we summarize what we consider are major contributions resulting from the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) program, including its key findings and key messages from those findings. Briefly, SCORE's key findings are as follows: i) biennial mass drug administration (MDA) with praziquantel can control schistosomiasis to moderate levels of prevalence; ii) MDA alone will not achieve elimination; iii) to attain and sustain control throughout endemic areas, persistent hotspots need to be identified following a minimal number of years of annual MDA and controlled through adaptive strategies; iv) annual MDA is more effective than biennial MDA in high-prevalence areas; v) the current World Health Organization thresholds for decision-making based on the prevalence of heavy infections should be redefined; and vi) point-of-care circulating cathodic antigen urine assays are useful for

Indexed as

Health Planning GuidelinesAfricaAnimalsAnthelminticsAntigens, HelminthBiomarkersChildFecesGlycoproteinsHelminth ProteinsHumansMaleMass Drug AdministrationNeglected DiseasesParasite Egg CountPraziquantelAnthelminticsAntigens, HelminthBiomarkersCCA protein, Schistosoma mansoniGlycoproteinsHelminth ProteinsPraziquantel

Identifiers

PMID32400345
PMCPMC7351304
OpenAlexW3024494427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.